A Study of MK0476 in the Treatment of Asthma Patients Aged 2-5 Years (0476-907)

• Status: Completed
• Trial end date: 2002-12-01
• Target enrollment: 0
• Participant gender: All

Summary

A study to determine the efficacy of MK0476 in the Treatment of Asthmatic Patients Aged 2 to 5 Years.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Montelukast

Criteria

Inclusion Criteria:

• Male or Female between and including the ages of 2 and 5 years

• Patient was treated with steroids for an asthma episode in the last 3 months

• Patient was admitted to the hospital or emergency room in the last 3 months

• Patient is able to chew a tablet

Exclusion Criteria:

• Patient has been in a research study in the past 4 weeks

• Patient has visited the emergency room for an asthma episode in the past week

• Patients has a history of stomach, heart, liver, nerve, kidney or blood disease